Skip to main content
Erschienen in:

06.04.2021 | Original Article

Cardiac microcalcification burden: Global assessment in high cardiovascular risk subjects with Na[18F]F PET-CT

verfasst von: João Borges-Rosa, MD, Manuel Oliveira-Santos, MD, Rodolfo Silva, MD, Nuno Pereira da Silva, MD, Antero Abrunhosa, PhD, Miguel Castelo-Branco, MD, PhD, Lino Gonçalves, MD, PhD, Maria João Ferreira, MD, PhD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Fluorine-18 sodium fluoride (Na[18F]F) atherosclerotic plaque uptake in positron emission tomography with computed tomography (PET-CT) identifies active microcalcification. We aim to evaluate global cardiac microcalcification activity with Na[18F]F, as a measure of unstable microcalcification burden, in high cardiovascular (CV) risk patients.

Methods and Results

Thirty-four high CV risk individuals without previous CV events were scanned with Na[18F]F PET-CT. Cardiac Na[18F]F uptake was assessed through the global molecular calcium score (GMCS), which was calculated by summing the product of the mean standardized uptake value times the area of the cardiac regions of interest times the slice thickness for all cardiac transaxial slices, divided by the total number of slices. Mean age is 63.5 ± 7.8 years and 62% male. Median GMCS is 320.9 (240.8-402.8). Individuals with more than five CV risk factors (50%) have increased GMCS [356.7 (321.0-409.6) vs. 261.1 (225.6-342.1), P = 0.01], which is positively correlated with predicted fatal CV risk by SCORE (rs = 0.32, P = 0.04). There is a positive correlation between GMCS and weight (rs = 0.61), body mass index (rs = 0.66), abdominal perimeter (rs = 0.74), thoracic fat volume (rs = 0.47), and epicardial adipose tissue (rs = 0.41), all with P ≤ 0.01. There is no correlation between GMCS and coronary calcium score nor coronary artery wall Na[18F]F uptake.

Conclusions

In a high CV risk group, the global cardiac microcalcification burden is related to CV risk factors, metabolic syndrome variables and cardiac fat. Cardiac GMCS is a promising risk stratification tool, combining a straightforward and objective methodology with a comprehensive analysis of both coronary and valvular microcalcification.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Saraste A, Barbato E, Capodanno D, Edvardsen T, Prescott E, Achenbach S, et al. Imaging in ESC clinical guidelines: Chronic coronary syndromes. Eur Heart J Cardiovasc Imaging 2019;20:1187-97.CrossRef Saraste A, Barbato E, Capodanno D, Edvardsen T, Prescott E, Achenbach S, et al. Imaging in ESC clinical guidelines: Chronic coronary syndromes. Eur Heart J Cardiovasc Imaging 2019;20:1187-97.CrossRef
2.
Zurück zum Zitat Mach F, Baigent C, Catapano A, Koskinas K, Casula M, Badimon L, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140-205. Mach F, Baigent C, Catapano A, Koskinas K, Casula M, Badimon L, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140-205.
3.
Zurück zum Zitat Blaha MJ, Mortensen MB, Kianoush S, Tota-Maharaj R, Cainzos-Achirica M. Coronary artery calcium scoring: Is it time for a change in methodology? JACC Cardiovasc Imaging 2017;10:923-37.CrossRef Blaha MJ, Mortensen MB, Kianoush S, Tota-Maharaj R, Cainzos-Achirica M. Coronary artery calcium scoring: Is it time for a change in methodology? JACC Cardiovasc Imaging 2017;10:923-37.CrossRef
5.
Zurück zum Zitat Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology. J Am Coll Cardiol 2012;59:1539-48.CrossRef Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology. J Am Coll Cardiol 2012;59:1539-48.CrossRef
6.
Zurück zum Zitat Czernin J, Satyamurthy N, Schiepers C. Molecular mechanisms of bone 18F-NaF deposition. J Nucl Med 2010;51:1826-9.CrossRef Czernin J, Satyamurthy N, Schiepers C. Molecular mechanisms of bone 18F-NaF deposition. J Nucl Med 2010;51:1826-9.CrossRef
7.
Zurück zum Zitat Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun 2015;6:7495.CrossRef Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun 2015;6:7495.CrossRef
8.
Zurück zum Zitat Derlin T, Richter U, Bannas P, Begemann P, Buchert R, Mester J, et al. Feasibility of 18F-sodium fluoride PET/CT for imaging of atherosclerotic plaque. J Nucl Med 2010;51:862-5.CrossRef Derlin T, Richter U, Bannas P, Begemann P, Buchert R, Mester J, et al. Feasibility of 18F-sodium fluoride PET/CT for imaging of atherosclerotic plaque. J Nucl Med 2010;51:862-5.CrossRef
9.
Zurück zum Zitat Moghbel M, Al-Zaghal A, Werner TJ, Constantinescu CM, Hoilund-Carlsen PF, Alavi A. The role of PET in evaluating atherosclerosis: A critical review. Semin Nucl Med 2018;48:488-97.CrossRef Moghbel M, Al-Zaghal A, Werner TJ, Constantinescu CM, Hoilund-Carlsen PF, Alavi A. The role of PET in evaluating atherosclerosis: A critical review. Semin Nucl Med 2018;48:488-97.CrossRef
10.
Zurück zum Zitat Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 2014;383:705-13.CrossRef Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 2014;383:705-13.CrossRef
11.
Zurück zum Zitat Beheshti M, Saboury B, Mehta NN, Torigian DA, Werner T, Mohler E, et al. Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography-a novel concept. Hell J Nucl Med 2011;14:114-20.PubMed Beheshti M, Saboury B, Mehta NN, Torigian DA, Werner T, Mohler E, et al. Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography-a novel concept. Hell J Nucl Med 2011;14:114-20.PubMed
12.
Zurück zum Zitat Oliveira-Santos M, Castelo-Branco M, Silva R, Gomes A, Chichorro N, Abrunhosa A, et al. Atherosclerotic plaque metabolism in high cardiovascular risk subjects: A subclinical atherosclerosis imaging study with (18)F-NaF PET-CT. Atherosclerosis 2017;260:41-6.CrossRef Oliveira-Santos M, Castelo-Branco M, Silva R, Gomes A, Chichorro N, Abrunhosa A, et al. Atherosclerotic plaque metabolism in high cardiovascular risk subjects: A subclinical atherosclerosis imaging study with (18)F-NaF PET-CT. Atherosclerosis 2017;260:41-6.CrossRef
13.
Zurück zum Zitat Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:2315-81.CrossRef Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:2315-81.CrossRef
14.
Zurück zum Zitat Rawlings R, Nohria A, Liu PY, Donnelly J, Creager MA, Ganz P, et al. Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event. Am J Cardiol 2009;103:437-41.CrossRef Rawlings R, Nohria A, Liu PY, Donnelly J, Creager MA, Ganz P, et al. Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event. Am J Cardiol 2009;103:437-41.CrossRef
15.
Zurück zum Zitat Domingues C, Joao Ferreira M, Silva R, Oliveira-Santos M, Andreia G, Chichorro N, et al. Aortic valve microcalcification and cardiovascular risk: An exploratory study using sodium fluoride in high cardiovascular risk patients. Int J Cardiovasc Imaging 2020;36:1593-8.CrossRef Domingues C, Joao Ferreira M, Silva R, Oliveira-Santos M, Andreia G, Chichorro N, et al. Aortic valve microcalcification and cardiovascular risk: An exploratory study using sodium fluoride in high cardiovascular risk patients. Int J Cardiovasc Imaging 2020;36:1593-8.CrossRef
16.
Zurück zum Zitat Ferreira MJV, Oliveira-Santos M, Silva R, Gomes A, Ferreira N, Abrunhosa A, et al. Assessment of atherosclerotic plaque calcification using F18-NaF PET-CT. J Nucl Cardiol 2018;25:1733-41.CrossRef Ferreira MJV, Oliveira-Santos M, Silva R, Gomes A, Ferreira N, Abrunhosa A, et al. Assessment of atherosclerotic plaque calcification using F18-NaF PET-CT. J Nucl Cardiol 2018;25:1733-41.CrossRef
17.
Zurück zum Zitat Dey D, Nakazato R, Li D, Berman DS. Epicardial and thoracic fat: Noninvasive measurement and clinical implications. Cardiovasc Diagn Ther 2012;2:85-93.PubMedPubMedCentral Dey D, Nakazato R, Li D, Berman DS. Epicardial and thoracic fat: Noninvasive measurement and clinical implications. Cardiovasc Diagn Ther 2012;2:85-93.PubMedPubMedCentral
18.
Zurück zum Zitat Oliveira-Santos M, McMahon G, Castelo- Branco M, Silva R, Gomes A, Chichorro N, et al. Renal artery wall 18F-NaF activity and glomerular filtration rate: An exploratory analysis in a high cardiovascular risk population. Nucl Med Commun. 2020;41:126-32.CrossRef Oliveira-Santos M, McMahon G, Castelo- Branco M, Silva R, Gomes A, Chichorro N, et al. Renal artery wall 18F-NaF activity and glomerular filtration rate: An exploratory analysis in a high cardiovascular risk population. Nucl Med Commun. 2020;41:126-32.CrossRef
19.
Zurück zum Zitat McKenney-Drake ML, Moghbel MC, Paydary K, Alloosh M, Houshmand S, Moe S, et al. (18)F-NaF and (18)F-FDG as molecular probes in the evaluation of atherosclerosis. Eur J Nucl Med Mol Imaging 2018;45:2190-200.CrossRef McKenney-Drake ML, Moghbel MC, Paydary K, Alloosh M, Houshmand S, Moe S, et al. (18)F-NaF and (18)F-FDG as molecular probes in the evaluation of atherosclerosis. Eur J Nucl Med Mol Imaging 2018;45:2190-200.CrossRef
20.
Zurück zum Zitat Grant PJ, Cosentino F. The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: New features and the ‘Ten Commandments’ of the 2019 Guidelines are discussed by Professor Peter J. Grant and Professor Francesco Cosentino, the Task Force chairmen. Eur Heart J 2019;40:3215-7.CrossRef Grant PJ, Cosentino F. The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: New features and the ‘Ten Commandments’ of the 2019 Guidelines are discussed by Professor Peter J. Grant and Professor Francesco Cosentino, the Task Force chairmen. Eur Heart J 2019;40:3215-7.CrossRef
21.
Zurück zum Zitat Chen W, Dilsizian V. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: Microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose. Curr Cardiol Rep 2013;15:364.CrossRef Chen W, Dilsizian V. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: Microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose. Curr Cardiol Rep 2013;15:364.CrossRef
22.
Zurück zum Zitat Spearman JV, Renker M, Schoepf UJ, Krazinski AW, Herbert TL, De Cecco CN, et al. Prognostic value of epicardial fat volume measurements by computed tomography: A systematic review of the literature. Eur Radiol. 2015;25:3372-81.CrossRef Spearman JV, Renker M, Schoepf UJ, Krazinski AW, Herbert TL, De Cecco CN, et al. Prognostic value of epicardial fat volume measurements by computed tomography: A systematic review of the literature. Eur Radiol. 2015;25:3372-81.CrossRef
23.
Zurück zum Zitat Tamarappoo B, Dey D, Shmilovich H, Nakazato R, Gransar H, Cheng VY, et al. Increased pericardial fat volume measured from noncontrast CT predicts myocardial ischemia by SPECT. JACC Cardiovasc Imaging 2010;3:1104-12.CrossRef Tamarappoo B, Dey D, Shmilovich H, Nakazato R, Gransar H, Cheng VY, et al. Increased pericardial fat volume measured from noncontrast CT predicts myocardial ischemia by SPECT. JACC Cardiovasc Imaging 2010;3:1104-12.CrossRef
24.
Zurück zum Zitat Ito T, Nasu K, Terashima M, Ehara M, Kinoshita Y, Ito T, et al. The impact of epicardial fat volume on coronary plaque vulnerability: Insight from optical coherence tomography analysis. Eur Heart J Cardiovasc Imaging 2012;13:408-15.CrossRef Ito T, Nasu K, Terashima M, Ehara M, Kinoshita Y, Ito T, et al. The impact of epicardial fat volume on coronary plaque vulnerability: Insight from optical coherence tomography analysis. Eur Heart J Cardiovasc Imaging 2012;13:408-15.CrossRef
25.
Zurück zum Zitat Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739-91.CrossRef Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739-91.CrossRef
26.
Zurück zum Zitat Dweck MR, Jones C, Joshi NV, Fletcher AM, Richardson H, White A, et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 2012;125:76-86.CrossRef Dweck MR, Jones C, Joshi NV, Fletcher AM, Richardson H, White A, et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 2012;125:76-86.CrossRef
27.
Zurück zum Zitat Rojulpote C, Borja AJ, Zhang V, Aly M, Koa B, Seraj SM, et al. Role of (18)F-NaF-PET in assessing aortic valve calcification with age. Am J Nucl Med Mol Imaging 2020;10:47-56.PubMedPubMedCentral Rojulpote C, Borja AJ, Zhang V, Aly M, Koa B, Seraj SM, et al. Role of (18)F-NaF-PET in assessing aortic valve calcification with age. Am J Nucl Med Mol Imaging 2020;10:47-56.PubMedPubMedCentral
28.
Zurück zum Zitat Massera D, Trivieri MG, Andrews JPM, Sartori S, Abgral R, Chapman AR, et al. Disease activity in mitral annular calcification. Circ Cardiovasc Imaging 2019;12:CrossRef Massera D, Trivieri MG, Andrews JPM, Sartori S, Abgral R, Chapman AR, et al. Disease activity in mitral annular calcification. Circ Cardiovasc Imaging 2019;12:CrossRef
29.
Zurück zum Zitat Arbab-Zadeh A, Fuster V. The myth of the “vulnerable plaque”: Transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol 2015;65:846-55.CrossRef Arbab-Zadeh A, Fuster V. The myth of the “vulnerable plaque”: Transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol 2015;65:846-55.CrossRef
Metadaten
Titel
Cardiac microcalcification burden: Global assessment in high cardiovascular risk subjects with Na[18F]F PET-CT
verfasst von
João Borges-Rosa, MD
Manuel Oliveira-Santos, MD
Rodolfo Silva, MD
Nuno Pereira da Silva, MD
Antero Abrunhosa, PhD
Miguel Castelo-Branco, MD, PhD
Lino Gonçalves, MD, PhD
Maria João Ferreira, MD, PhD
Publikationsdatum
06.04.2021
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 4/2022
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-021-02600-2

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Kardiologie

Herzkongress ACC 2025: Diese neuen Studien stehen im Brennpunkt

Vom 29. bis 31. März findet in Chicago der Herzkongress ACC 2025 statt. Die Liste der als „Late-breaking Trials“ in den Blickpunkt gerückten neuen Studien zu wichtigen kardiologischen Themen ist wieder einmal lang.

Blutdruck am Belastungsende zeigt kardiovaskuläres Risiko

Diverse Blutdruckparameter während der Ergometrie sind schon auf ihre Aussagekraft, Mortalität und kardiovaskuläres Risiko betreffend, hin abgeklopft worden. Nun hat auch das Druckverhalten am Ende der Belastung im Fokus einer Studie gestanden.

Lp(a) wird zu selten gemessen

Laut europäischer Dyslipidämie-Leitlinie sollte die Bestimmung der Serumkonzentration von Lipoprotein (a) mindestens einmal im Leben jedes Erwachsenen erwogen werden. Tatsächlich wird die Messung selbst kardiovaskulär gefährdeten Personen nur selten zuteil.

Neue US-Leitlinie zum Management bei akutem Koronarsyndrom

In den USA ist die Leitlinie zum Management bei akutem Koronarsyndrom aktualisiert worden. In Europa erfolgte das neueste Guideline-Update dazu bereits 2023. Gehen beide Leitlinien konform oder gibt es nennenswerte Differenzen? 

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.